
pmid: 11419963
The current tests for bioequivalence are based on assumptions that are not valid in general; this paper shows why it is necessary to use a method that does not depend upon assumptions that cannot, and need not, be proved in general.
Time Factors, Therapeutic Equivalency, United States Food and Drug Administration, Area Under Curve, Humans, Guidelines as Topic, Pharmacokinetics, United States
Time Factors, Therapeutic Equivalency, United States Food and Drug Administration, Area Under Curve, Humans, Guidelines as Topic, Pharmacokinetics, United States
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
